These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17639043)

  • 1. Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer.
    Vaclavicek A; Bermejo JL; Schmutzler RK; Sutter C; Wappenschmidt B; Meindl A; Kiechle M; Arnold N; Weber BH; Niederacher D; Burwinkel B; Bartram CR; Hemminki K; Försti A
    Endocr Relat Cancer; 2007 Jun; 14(2):267-77. PubMed ID: 17639043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph).
    Butterbach K; Beckmann L; de Sanjosé S; Benavente Y; Becker N; Foretova L; Maynadie M; Cocco P; Staines A; Boffetta P; Brennan P; Nieters A
    Br J Haematol; 2011 May; 153(3):318-33. PubMed ID: 21418178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic factors in chronic inflammation: single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population.
    Ferguson LR; Han DY; Fraser AG; Huebner C; Lam WJ; Morgan AR; Duan H; Karunasinghe N
    Mutat Res; 2010 Aug; 690(1-2):108-15. PubMed ID: 20109474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer.
    Wagner K; Hemminki K; Israelsson E; Grzybowska E; Klaes R; Chen B; Butkiewicz D; Pamula J; Pekala W; Försti A
    Endocr Relat Cancer; 2005 Dec; 12(4):917-28. PubMed ID: 16322331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity.
    Angèle S; Romestaing P; Moullan N; Vuillaume M; Chapot B; Friesen M; Jongmans W; Cox DG; Pisani P; Gérard JP; Hall J
    Cancer Res; 2003 Dec; 63(24):8717-25. PubMed ID: 14695186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex genotyping of 1107 SNPs from 232 candidate genes identified an association between IL1A polymorphism and breast cancer risk.
    Han W; Kang SY; Kang D; Park SK; Lee JY; Kim H; Park AK; Noh DY
    Oncol Rep; 2010 Mar; 23(3):763-9. PubMed ID: 20127018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients.
    Suga T; Ishikawa A; Kohda M; Otsuka Y; Yamada S; Yamamoto N; Shibamoto Y; Ogawa Y; Nomura K; Sho K; Omura M; Sekiguchi K; Kikuchi Y; Michikawa Y; Noda S; Sagara M; Ohashi J; Yoshinaga S; Mizoe J; Tsujii H; Iwakawa M; Imai T
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):685-93. PubMed ID: 17889263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis.
    Varadi V; Brendle A; Brandt A; Johansson R; Enquist K; Henriksson R; Svenson U; Tavelin B; Roos G; Hemminki K; Lenner P; Försti A
    Eur J Cancer; 2009 Nov; 45(17):3008-16. PubMed ID: 19766477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mining for JAK-STAT mutations in cancer.
    Constantinescu SN; Girardot M; Pecquet C
    Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.
    Johnatty SE; Spurdle AB; Beesley J; Chen X; Hopper JL; Duffy DL; Chenevix-Trench G;
    Breast Cancer Res Treat; 2008 May; 109(1):91-9. PubMed ID: 17592773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
    Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk.
    Frank B; Hemminki K; Shanmugam KS; Meindl A; Klaes R; Schmutzler RK; Wappenschmidt B; Untch M; Bugert P; Bartram CR; Burwinkel B
    Carcinogenesis; 2005 Nov; 26(11):1975-7. PubMed ID: 15975957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The XRCC1 -77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage.
    Brem R; Cox DG; Chapot B; Moullan N; Romestaing P; Gérard JP; Pisani P; Hall J
    Carcinogenesis; 2006 Dec; 27(12):2469-74. PubMed ID: 16829685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer?
    Tulupova E; Kumar R; Hanova M; Slyskova J; Pardini B; Polakova V; Naccarati A; Vodickova L; Novotny J; Halamkova J; Hemminki K; Vodicka P
    Mutat Res; 2008 Dec; 648(1-2):40-5. PubMed ID: 18851982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
    Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
    Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNPs in ultraconserved elements and familial breast cancer risk.
    Yang R; Frank B; Hemminki K; Bartram CR; Wappenschmidt B; Sutter C; Kiechle M; Bugert P; Schmutzler RK; Arnold N; Weber BH; Niederacher D; Meindl A; Burwinkel B
    Carcinogenesis; 2008 Feb; 29(2):351-5. PubMed ID: 18174240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence.
    Stevens VL; McCullough ML; Pavluck AL; Talbot JT; Feigelson HS; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1140-7. PubMed ID: 17548676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal transducers and activators of transcription (STATs) gene polymorphisms related with susceptibility to rheumatic heart disease in north Indian population.
    Gupta U; Mir SS; Srivastava A; Garg N; Agarwal SK; Pande S; Mittal B
    Immunol Lett; 2014 Sep; 161(1):100-5. PubMed ID: 24797343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk.
    Frank B; Hemminki K; Wirtenberger M; Bermejo JL; Bugert P; Klaes R; Schmutzler RK; Wappenschmidt B; Bartram CR; Burwinkel B
    Carcinogenesis; 2005 Mar; 26(3):643-7. PubMed ID: 15550452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3 gene polymorphisms and susceptibility to non-small cell lung cancer.
    Jiang B; Zhu ZZ; Liu F; Yang LJ; Zhang WY; Yuan HH; Wang JG; Hu XH; Huang G
    Genet Mol Res; 2011 Aug; 10(3):1856-65. PubMed ID: 21948749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.